Page last updated: 2024-10-21

tacrine and Lewy Body Disease

tacrine has been researched along with Lewy Body Disease in 4 studies

Tacrine: A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders.
tacrine : A member of the class of acridines that is 1,2,3,4-tetrahydroacridine substituted by an amino group at position 9. It is used in the treatment of Alzheimer's disease.

Lewy Body Disease: A neurodegenerative disease characterized by dementia, mild parkinsonism, and fluctuations in attention and alertness. The neuropsychiatric manifestations tend to precede the onset of bradykinesia, MUSCLE RIGIDITY, and other extrapyramidal signs. DELUSIONS and visual HALLUCINATIONS are relatively frequent in this condition. Histologic examination reveals LEWY BODIES in the CEREBRAL CORTEX and BRAIN STEM. SENILE PLAQUES and other pathologic features characteristic of ALZHEIMER DISEASE may also be present. (From Neurology 1997;48:376-380; Neurology 1996;47:1113-1124)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Josif, S1
Graham, K1
Simard, M1
van Reekum, R1
Ringman, JM1
Cummings, JL1
Ballard, CG1
Chalmers, KA1
Todd, C1
McKeith, IG1
O'Brien, JT1
Wilcock, G1
Love, S1
Perry, EK1

Reviews

3 reviews available for tacrine and Lewy Body Disease

ArticleYear
Diagnosis and treatment of dementia with Lewy bodies.
    JAAPA : official journal of the American Academy of Physician Assistants, 2008, Volume: 21, Issue:5

    Topics: Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Lewy Body Disease; Nootropic Agen

2008
The acetylcholinesterase inhibitors for treatment of cognitive and behavioral symptoms in dementia with Lewy bodies.
    The Journal of neuropsychiatry and clinical neurosciences, 2004,Fall, Volume: 16, Issue:4

    Topics: Aged; Basal Ganglia Diseases; Behavior; Cholinesterase Inhibitors; Clinical Trials as Topic; Cogniti

2004
Current and emerging pharmacological treatment options for dementia.
    Behavioural neurology, 2006, Volume: 17, Issue:1

    Topics: Acetylcholine; Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Donepezil; Galantamine; Human

2006

Other Studies

1 other study available for tacrine and Lewy Body Disease

ArticleYear
Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies.
    Neurology, 2007, May-15, Volume: 68, Issue:20

    Topics: Aged; Aged, 80 and over; Amyloid beta-Peptides; Autopsy; Cerebral Cortex; Cholinesterase Inhibitors;

2007